EDP-305
EDP 305-009
Phase 1 small_molecule completed
Quick answer
EDP-305 for NASH - Nonalcoholic Steatohepatitis is a Phase 1 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- ENANTA PHARMACEUTICALS INC
- Indication
- NASH - Nonalcoholic Steatohepatitis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed